Full length cDNA coding for dentin matrix protein 1 (DMP1) has been cloned and sequenced, but the corresponding complete protein has not been isolated. In searching for naturally occurring DMP1, we recently discovered that the extracellular matrix of bone contains fragments originating from DMP1. Shortened forms of DMP1, termed 37K and 57K fragments, were treated with alkaline phosphatase and then digested with trypsin. Resultant peptides were purified by a two-dimensional method: size-exclusion followed by reversed-phase high performance liquid chromatography. Purified peptides were sequenced by Edman degradation and mass spectrometry, and the sequences compared to the DMP1 sequence predicted from cDNA. Extensive sequencing of tryptic peptides revealed that the 37K fragments originated from the NH 2 -terminal region, and the 57K fragments were from the COOH-terminal part of DMP1.
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SUMMARY
Full length cDNA coding for dentin matrix protein 1 (DMP1) has been cloned and sequenced, but the corresponding complete protein has not been isolated. In searching for naturally occurring DMP1, we recently discovered that the extracellular matrix of bone contains fragments originating from DMP1. Shortened forms of DMP1, termed 37K and 57K fragments, were treated with alkaline phosphatase and then digested with trypsin. Resultant peptides were purified by a two-dimensional method: size-exclusion followed by reversed-phase high performance liquid chromatography. Purified peptides were sequenced by Edman degradation and mass spectrometry, and the sequences compared to the DMP1 sequence predicted from cDNA. Extensive sequencing of tryptic peptides revealed that the 37K fragments originated from the NH 2 -terminal region, and the 57K fragments were from the COOH-terminal part of DMP1.
Phosphate analysis indicated that the 37K fragments contained 12 phosphates and the 57K fragments had 41. From 37K fragments, two peptides lacked a COOH-terminal lysine or arginine; instead they ended at Phe 173 and Ser 180 and were thus COOH-termini of 37K fragments.
Two peptides were from the NH 2 -termini of 57K fragments, starting at Asp 218 and Asp 222 . These findings indicated that DMP1 is proteolytically cleaved at four bonds, Phe 173 -Asp 174 , Ser 180 -
INTRODUCTION
During osteogenesis and dentinogenesis, osteoblasts and odontoblasts secrete a unique set of noncollagenous proteins (NCPs) 1 
into their extracellular matrix (ECM). One category of
NCPs is termed the SIBLING family that includes bone sialoprotein (BSP), osteopontin (OPN), dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP1), and matrix extracellular phosphoglycoprotein (1) . These SIBLING family members share some common features such as the presence of relatively large amounts of sialic acid, phosphate, and the RGD cell-binding sequence as well as similarities in genomic organization and chromosomal localizations (1, 2) .
These proteins are very acidic and are secreted into the ECM during the formation and mineralization of these tissues; it is generally accepted that they play key biological roles in the formation of bone and dentin (3, 4) ; however, details concerning their precise functions are unknown.
Among SIBLING family members, the full-length forms of OPN and BSP have been isolated from ECM and fully characterized (5, 6) . Although DSPP has never been detected in tissue, its cleavage products, dentin sialoprotein (DSP) and dentin phosphoprotein (DPP), have been isolated from dentin and thoroughly characterized (7) (8) (9) . In contrast, there is a lack of information about the characteristics and functions of naturally occurring DMP1 with complete structures (primary sequence with posttranslational modifications such as glycosylation and phosphorylation).
DMP1, first identified by cDNA cloning using a rat odontoblast mRNA library, is a very acidic phosphoprotein (10) . It was originally postulated to be dentin-specific, but later, its expression was observed in bone and brain (11, 12) . The cDNA of DMP1 has been cloned and sequenced in a number of species including rat (10), mouse (11) , bovine (12) , human (13), 4 wallaby (14) , opossum (14) , platypus (14) , caiman (15) and chicken (16) . The characteristic feature of DMP1 is that it contains an unusually large number of acidic domains, a property that implicates it as a possible participant in regulating matrix mineralization (10, 17) . Using an antibody monospecific to recombinant rat DMP1 to perform Western immunoblotting, George et al. (10) detected a band at an Mr of 61 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of dentin extracts and concluded that this 61 kDa band was a fulllength DMP1. Later, Srinivasan et al. (18) from the same group reported that the molecular weight of recombinant rat DMP1, determined by SDS-PAGE, was approximately 90-95 kDa, higher than that of the naturally occurring 61 kDa form of DMP1. According to the cDNAdeduced amino acid sequence, more than 55 of the 107 serine residues in the secreted rat DMP1
could be phosphorylated (10) . Additionally, 10 threonine residues were potential phosphorylation sites for casein kinase I and II. Thus, the native form of DMP1 with posttranslational modifications would be expected to be larger than the recombinant protein. This discrepancy relative to the experimentally determined molecular weights remains unresolved.
Recombinant DMP1 has been synthesized and used for functional studies (19, 20) .
Although the use of recombinant DMP1 either produced in prokaryotic or eukaryotic cells may provide significant clues about its biological functions, conclusions drawn from such studies may not fully reflect its actual role in vivo. One of the major shortcomings relative to recombinant protein is a variation in posttranslational modifications such as proteolytic processing, phosphorylation and glycosylation. Although recombinant DMP1 can be posttranslationally modified by eukaryotic cell lines, these cells do not provide a microenvironment that exactly mimics the biosynthetic and transport environments in bone or dentin cells. Hence, there is a necessity for isolating DMP1 from bone or dentin, fully characterizing it and performing by guest on September 1, 2017
http://www.jbc.org/ Downloaded from 5 functional studies. In searching for naturally occurring forms of DMP1 in bone and dentin, we discovered two clusters of proteins (37K and 57K fragments) that we speculated were fragments of DMP1 because we cleaved the mixture with trypsin and obtained sequences originating from DMP1 (21) . The purpose of the present study was to isolate and characterize these fragments, and in particular, to identify the cleavage site(s) at which DMP1 is proteolytically processed.
EXPERIMENTAL PROCEDURES
Isolation of 37K and 57K Fragments
ECM proteins were extracted from rat long bone by standard procedures as described (5, 22) . The extracts were first subjected to gel chromatography on Sephacryl S-200 (Amersham Biosciences AB) to separate the high molecular weight protein fraction from smaller-sized proteins; the latter eluted in an included volume. With DEAE-Sephacel (Pharmacia LKB Biotechnology) ion-exchange chromatography, the high molecular weight protein fraction was next separated into seven major fractions that were named D1, D2, D3, D4a, D4b, D5a, and D5b, corresponding to the elution gradient ranging from 0 to 0.53 M NaCl (2, 5) . In D4b, fragments of DMP1 (namely 37K and 57K) co-eluted with BSP and OPN (Fig. 1A) . Fraction D4b was further divided into five subfractions (2) . For purification of 37K fragments, subfractions mostly rich in this protein were passed over a Bio-Gel A15m column (Bio-Rad Laboratories). This step eliminated OPN and partially removed BSP and 57K fragments. Finally, the fractions enriched in 37K fragments from Bio-Gel A15m chromatography were passed over a Mono-Q column (Amersham Pharmacia Biotech AB) connected to a fast protein liquid chromatography (FPLC)
system. Thus, a sample for 37K fragments of relatively high purity was obtained (Fig.1B) 
Alkaline Phosphatase Treatment and Trypsin Digestion
Prior to trypsin digestion, 37K and 57K fragments were dephosphorylated with calf intestine alkaline phosphatase (Sigma) attached to 150 µm oxirane-activated macroporous acrylic beads. Four hundred µg of 37K and 57K fragments, respectively, were incubated for 4 h at 37 0 C in the presence of 4 units of alkaline phosphatase in 100 mM Tris-HCl, pH 8.0 (total volume 0.5 ml). Following dephosphorylation, proteins were digested overnight at 37 0 C with trypsin (Roche Molecular Biochemicals) at an enzyme:substrate ratio of 1:50 (by weight) in 100 mM Tris-HCl, pH 8.0 (total volume 0.5 ml). The final concentration of trypsin was 16 µg/ml. Prior to the addition of trypsin, the chymotrypsin inhibitor TPCK (Roche Molecular Biochemicals) was added to a final concentration of 100 µg/ml to inhibit possible chymotrypsin activity.
Peptide Purification
Following trypsin digestion, direct separation of peptides by reversed-phase high performance liquid chromatography (HPLC) gave rise to a large number of overlapping peptide peaks; our past experience has shown that this level of separation does not yield optimal data for structure determinations. Therefore, peptides were separated using a two-dimensional approach to produce a series of pure peptides for unambiguous characterization. In the first phase, peptides
were separated according to size on Superdex 75 HR 10/30 (Amersham Pharmacia Biotech AB) equilibrated and eluted at 0.5 ml/min in 4 M GdmCl (SigmaUltra, pH 6.0). Using FPLC, the eluant was monitored at 280 nm. The 30 ml elution volume was collected as 60 0.5 ml fractions.
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Tryptic peptides from 37K and 57K fragments eluted in a volume of 10-17 ml. Fractions containing peptides ranging in size from 4 amino acids (fraction 32) to 50 amino acids (fraction 22) were selected for a second phase HPLC separation. Each selected fraction was subjected to HPLC using a 2.1 x 250 mm C18 reversed-phase column (Vydac). After applying the sample, the column was washed with water (0% acetonitrile) for 20 min before starting a 0-35% acetonitrile linear gradient in 0.1% trifluoroacetic acid (100 min at a flow rate of 300 µl/min).
For all HPLC separations, the eluant was monitored at 218 nm and peaks were collected manually.
Sequence Analysis and Determination of Mass
Most purified peptides from HPLC were first sequenced by Edman degradation on an Applied Biosystems ABI Procise 492cLC or 477A Sequencer using standard techniques. Next, those that could not be fully sequenced by Edman degradation were further analyzed for Karplus-Shulz algorithm predictive results were used to make models that were minimized using conjugate gradient iterations until the root mean square deviation (rmsd) was below 0.0001.
Results were displayed with Insight II (2000, Accelyrs) and the secondary structure render Kabsch-Sandler algorithm was utilized.
Amino Acid and Phosphate Analysis
For amino acid analysis, aliquots from samples of 37K and 57K fragments in water were dried, hydrolyzed by HCl gas (6M HCl) and analyzed with an ABI 420A Amino Acid Analyzer For phosphate analysis, aliquots of the 37K and 57K fragment solutions used for amino acid analysis were hydrolyzed in 0.2M NaOH at 37 0 C overnight. Concentrations of inorganic phosphate were measured (23) . For each sample, three independent values were obtained and averaged for calculating the phosphate contents of 37K and 57K fragments. Based on amino acid analysis, the molar concentrations of phosphate for each sample were determined and these values were then used to calculate the number of phosphates/mol.
RESULTS
The following section is organized in a systematic manner, designed to help the reader to more easily comprehend our findings and the scientific implications. Thus, the presentation of the results begins with isolation and characterization of fragments, gives analytical results for all the tryptic peptides and leads to the summation of the major conclusions about the sites of proteolytic processing.
Isolation of 37K and 57K Fragments
The purity of the 37K and 57K fragments was assessed by SDS-PAGE and Stains-All staining. As shown in Fig. 1B , the 37K fragments gave rise to a cluster of bands migrating between ~29 and ~37 kDa on 5-15% SDS-PAGE. On 7.5% SDS-PAGE, the major band of this set migrated at 37 kDa (hence named 37K fragments). On 5-15% SDS-PAGE, the 57K fragments gave rise to a cluster of bands migrating between ~45 and ~60 kDa (Fig. 1C) . On 7.5% SDS-PAGE, the major band of this sample migrated at 57 kDa (hence designated 57K fragments).
Despite the apparent heterogeneity, we concluded that both sets of protein fragments were derived from DMP1 as evidenced by the following. Amino acid sequencing (see later) of the tryptic peptides from each showed that every peptide we obtained was solely derived from 10 DMP1. Some minor peptides from trypsin itself were also detected, but we found no evidence for the presence of tryptic peptides from any contaminating proteins. Note that only 2% of the total protein was trypsin.
As shown in Figs. 1B and 1C, both 37K and 57K fragments displayed relatively broad clusters of protein bands on SDS-PAGE. To examine if the apparent heterogeneity in migration rate is due to variations in phosphorylation, we performed experiments to compare the migration rates of dephosphorylated 37K and 57K fragments with those of the non-dephosphorylated.
Although the dephosphorylated 37K and 57K fragments displayed migration rates slightly slower than the non-dephosphorylated (data not shown), the observed heterogeneity in migration rate remained the same before and after dephosphorylation. These results indicated that this heterogeneity in migration rate was not caused by difference in phosphorylation level. We speculate that this apparent heterogeneity in migration rate within the cluster of 37K or 57K fragments may be due to difference in fragment length and/or glycosylation level.
Separation of Tryptic Peptides Derived from 37K and 57K Fragments
When we first used trypsin to digest 37K and 57K fragments without dephosphorylation, only a few peptides were obtained in very low amounts. Realizing that a majority of trypsin cleavage sites might be blocked by protein bound phosphate, we then used alkaline phosphatase to remove phosphates prior to trypsin digestion. This significantly increased the level of cleavage, allowing a thorough analysis of a number of pure peptides from the 37K and 57K
fragments.
Examples of HPLC separation of tryptic peptides derived from 37K and 57K fragments are shown in Figs. 2 and 3, respectively. For both 37K and 57K fragments, we performed HPLC separations on Superdex 75 fractions 22 through 32. These 11 Superdex fractions included peptides ranging in size from 4 to 50 amino acids. 
Structures of Tryptic Peptides Derived from 37K and 57K Fragments
Fig . 4A is the cDNA-deduced amino acid sequence of rat DMP1 NH 2 -terminal region (10) . Amino acids are numbered from the NH 2 -terminus of DMP1, excluding the 16 amino acid signal peptide. Fig. 4B is a summary of tryptic peptides derived from 37K fragments, sequenced in this study. Fig . 5A shows the cDNA-deduced amino acid sequence of rat DMP1 COOH-terminal region (10) . Amino acids are numbered as described above. Fig. 5B 
Identification of COOH-termini of 37K Fragments
The identification of COOH-terminal peptides from 37K fragments, resulting from trypsin digestion, was made by searching for peptides with a COOH-terminal amino acid other than lysine or arginine. For a complete search, we sequenced all the major HPLC peaks containing peptides ranging in size from 4 to 50 amino acids (Superdex fractions 22-32). We identified two tryptic peptides from the COOH-termini of 37K fragments (Fig. 4B, were unable to detect any NH 2 -terminal peptides other than the two described above.
Secondary Structure Prediction for Sequences around Cleavage Sites
The identification of the COOH-termini of 37K fragments revealed that peptide bonds (Fig. 6B) . Note that the surrounding chain segments did not favor formation of any regular conformation.
Amino Acid and Phosphate Analysis
Amino acid analysis showed that the compositions of 37K and 57K fragments agreed closely with those calculated from the cDNA-deduced amino acid sequence, using Ser 180 as the end of 37K fragments, and Asp 218 as the beginning of 57K fragments (data not shown). Using the molar concentrations of these 37K and 57K fragments, and the phosphate contents of the same solutions, we calculated that 37K fragments had 12 phosphates/mol while 57K had 41. Using Ser 180 as the end of 37K fragments, we calculated that the average ratio of phosphate to amino acid residue was 1:15. With Asp 218 as the beginning of 57K fragments, this ratio for 57K was 1:6. These data indicate that the 57K fragments are more highly phosphorylated than 37K fragments.
DISCUSSION
In the present study, we isolated and characterized fragments derived from naturally occurring form of DMP1 in rat bone. Extensive sequencing of tryptic peptides derived from these fragments (Figs. 4B , 5B) shows unequivocally that they are derived from DMP1 and strongly suggest that this protein in bone is proteolytically processed into fragments, including 7A ). As shown in Fig. 7A , the longest 37K fragment has 221 amino acids (37K-221AA), the shortest one with 173 (37K-173AA). For 57K fragments, the longest fragment consists of 300 amino acids (57K-300AA) while the shortest one contains 252 amino acids (57K-252AA). A comparison of sequences around the four cleavage sites showed that all of the cleavages occurred at the NH 2 -terminus of an aspartic acid residue, three of them being immediately followed by an Asp-Asp motif (Fig. 7B ). These findings suggest that DMP1 is processed by a single proteinase that cleaves DMP1 at the NH 2 -terminus of an Asp residue. Although the proteinase catalyzing these scissions has not been directly identified at this time, we speculate that a tissue-specific enzyme, designed to activate DMP1 by cleaving it into 37K and 57K fragments, is involved. One possible candidate for the catalytic cleavage of DMP1 is a protein encoded by PHEX (phosphateregulating gene with homologies to endopeptidases on X chromosome) which is expressed predominantly in bone and tooth (25) (26) (27) (28) (29) (30) ). This conclusion is based on reports that PHEX protein has a strong preference for cleavage of peptide bonds at the NH 2 -terminus of aspartic acid residues (28, 31, 32). As discussed above, our data indicate that DMP1 is proteolytically processed in a similar fashion (Figs. 7A, 7B) . Mutations in the PHEX gene are associated with X-linked hypophosphatemic rickets in humans (33) and the murine homolog, Hyp (26) . PHEX 16 protein is a cell membrane-associated glycoprotein with structural homologies to members of the M13 family of metalloendopeptidases (28, 31, 33) . The M13 endopeptidases are zinc-containing type II integral membrane glycoproteins with a relatively short cytoplasmic NH 2 -terminal region, a single transmembrane domain, and a long extracytoplasmic domain, which contains the active site of the enzyme (34) . Immunohistochemical studies have demonstrated that signals for PHEX protein are stronger in osteocytes than in osteoblasts and localized predominantly on the plasma membrane (35) . Likewise, DMP1 in bone is more highly expressed in osteocytes than in osteoblasts (36, 37) . This coincidental localization of DMP1 and PHEX protein in osteocytes and osteoblasts strengthens the possibility that PHEX protein may be the proteinase involved in the processing of DMP1. Based on these data, it is tempting to speculate that, during or after secretion, DMP1 is processed by PHEX protein on cell surfaces, converting this SIBLING family member from an inactive precursor into active fragments.
Since there are many aspartic acid residues and quite a few Asp-Asp motifs in the DMP1 amino acid sequence, the fact that cleavages only occur at the four sites discussed above suggests that the scissions by the enzyme may relate to spatial structure of DMP1 in addition to conserved aspartic acid residues. The structure predictions suggest that three of the cleaved bonds, Phe 173 -Asp 174 , Ser 180 -Asp 181 and Gln 221 -Asp 222 , are located at the edges of a possible short (6-7 residues) α-helix. The Ser 217 -Asp 218 cleavage site was 4 residues NH 2 -terminal to the α-helix.
Although we cannot draw a firm conclusion based on the secondary structure predictions for the sequences around the cleavage sites, such data may provide clues about the selectivity of DMP1 bonds that are proteolytically processed. Further studies, designed to focus on the tertiary structure of DMP1, and on the substrate specificity of PHEX, are beyond the scope of this study. Fig. 7C shows an alignment of amino acid sequences of DMP1 from four species: rat (10), mouse (11), bovine (12) and human (13) . We selected a portion corresponding to rat DMP1 residues 155-234 that covers the four cleavage sites, for this alignment. An alignment of complete DMP1 amino acid sequences among the four species can be found in reference 13. It is worth noting that the flanking region (corresponding to rat DMP1 residues 165-183) of two cleaved bonds, Phe 173 -Asp 174 and Ser 180 -Asp 181 shows a high level of conservation among these species. In fact, this region is one of the three most highly conserved domains (the other two highly conserved domains are located in the NH-terminal and COOH-terminal regions of DMP1 sequence, respectively) (11, 13, 15) . Curiously, the sequences around the other two cleaved bonds, Ser 217 -Asp 218 and Gln 221 -Asp 222 display no apparent sequence conservation among these species.
DMP1 amino acid sequence deduced from cDNA indicates that the secreted rat DMP1
has 65 potential phosphorylation sites (10) . If fully phosphorylated, rat DMP1 would have an average of 0.137 phosphates for each residue. Phosphate analysis in the present study revealed that a full-length DMP1 contained 53 phosphates (12 for 37K fragments plus 41 for 57K fragments). In our previous studies with OPN and DSP peptides (24, 38) , we have noted that phosphoserines juxtaposed to lysine or arginine can prevent these residues from being cleaved by trypsin. In agreement with this observation, dephosphorylation of 37K and 57K fragments in the present study resulted in a more efficient digestion of these proteins by trypsin. In addition, dephosphorylation of DMP1 fragments reduces their acidity, thus increasing the hydrophobicity of many of their tryptic peptides, since phosphates are negatively charged. We believe that without dephosphorylation, certain numbers of the peptides obtained in the present study would not have been detected due to their inability to bind onto a reversed-phase C-18 column. One disadvantage of dephosphorylation is that we were unable to identify sites of phosphorylation.
We suggest that the present data provide insights into the processing of DSPP. It is well known that DSPP is processed into two fragments, DSP and DPP found in the ECM of dentin (39) . A previous study in our laboratory identified and characterized two COOH-terminal peptides for rat DSP (24) Interestingly, the two major cleavages in DSPP also occur at the NH 2 -terminus of Asp, one being immediately followed by an Asp-Asp motif (Ref. 24 , Fig. 4 ). Based on these similarities, we speculate that same enzyme (possibly, PHEX protein) and perhaps substrate conformation properties may be involved in the proteolytic processing of DMP1 and DSPP.
Phosphate analysis revealed that 57K fragments (COOH-terminal portion of DMP1) are more highly phosphorylated than 37K (NH 2 -terminal portion). We know that DPP (COOHterminal portion of DSPP) is much more highly phosphorylated than DSP (NH 2 -terminal portion) (9, 39, 40) . Experiments on the in vitro formation of hydroxyapatite and growth of the mineral crystals indicate that DSP has little or no effect on mineralization (41) whereas DPP actively regulates the formation and growth of hydroxyapatite in vitro (42) (43) (44) . We have previoulsy hypothesized that DSPP is an inactive precursor and its proteolytic processing is an activation step to release the functional fragment, DPP (45). Based on the similarities in chemical features and proteolytic processing between DMP1 and DSPP, we have formed a similar hypothesis about DMP1: that full-length DMP1 is an inactive precursor that requires processing to release functional molecules, 37K and/or 57K fragments. We believe that this proteolytic processing plays a significant, crucial role for the biological functions of DMP1 during osteogenesis and dentinogenesis. To address these issues, further investigations are needed to test the effects of 37K and 57K fragments as well as full-length DMP1 on mineralization.
Additionally, we have observed that dentin ECM contains 37K and 57K fragments. We have isolated 37K fragments from rat dentin. The HPLC chromatographic profile of tryptic peptides derived from dentin 37K fragments was identical to that obtained from bone 37K
fragments. Selective sequencing of tryptic peptides derived from 37K fragments indicated that the NH 2 -termini and COOH-termini of dentin 37K fragments were identical to those of bone.
Attempts to obtain pure dentin 57K fragments for sequence analysis have been unsuccessful. fragments appear as a cluster of bands migrating between ~29 and ~37 kDa. Arrow indicates that peptide in peak 1 was not fully sequenced. All cleavages occur at the NH 2 -terminus of an aspartic acid residue, three of them being immediately followed by an Asp-Asp motif. Vertical arrows indicate cleavage sites. by guest on September 1, 2017
